Navigation Links
New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product
Date:9/16/2007

Computer Assisted Surgery at the Forefront

SACRAMENTO, Calif., Sept. 16 /PRNewswire/ -- Novatrix Biomedical, Inc. announced today that it has formed a new company, Curexo Medical, Inc. (CMI), with the acquisition of all assets of Integrated Surgical Services, Inc. (ISS). Under the licensing agreement, Curexo, Inc., will transfer all the assets acquired from ISS to CMI.

Curexo Medical, Inc., located in Sacramento, California, retained the former officers and employees of ISS in order to facilitate rapid introduction of its surgical robotics system into the U.S. orthopedic market. The system is called ROBODOC(R) Surgical Assistant System (the ROBODOC). The ROBODOC has been very well received by hospitals and orthopedic surgeons from both academic institutions and private hospitals in Europe and Asia, including Japan, Korea and India. The system has already been approved by Korea's regulatory agency, KFDA.

"CMI's mission is to make computer assisted surgery a gold standard for all major orthopedic surgeries by the year 2012 and to be the world leader in this market segment," said Dr. Ramesh Trivedi, President and CEO.

"We have already received funding from Novatrix and have been assured of future funding to accomplish our goals," said Trivedi. "We are actively recruiting highly qualified and experienced staff to rapidly grow the business."

Novatrix Biomedical, Inc., based in Southern California, develops proprietary technologies in the drug delivery field. "We firmly believe that CMI has the right strategy, a well thought out plan and a highly experienced team in place to be a dominant player in the orthopedic surgical robotics field," said Dr. Soon Kap Hahn, President and CEO of Novatrix Biomedical.

"Along with our partner, Curexo Inc., Korea, we are committed to fund CMI to secure U.S. Food and Drug Administration (FDA) clearance, enter the U.S. market and continue building the ongoing business in other major markets of the world."

Curexo Medical, Inc. also announced that it has submitted a 510(k) pre-market notification to the U.S. FDA for the clearance of its ROBODOC Surgical Assistance System for marketing in the U.S. A 90-day period is customary for FDA review of a 510(k) submission.

http://www.robodoc.com

Contact: Media Contact

Dr. Ramesh C. Trivedi Tami Adachi

President & CEO 415-370-9638

Curexo Medical, Inc. tadachi@mindspring.com

916-285-9943, X511


'/>"/>
SOURCE Curexo, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Phillips Plastics to help develop orthopedics with stem cells
2. Evaluation of RNA isolated from human tissues: quality control for surgical and postmortem samples
3. Surgical products company wins Governors Business Plan Contest
4. Vector Surgical hopes to turn frustration into faster surgeries
5. KUKA Robotics set to unveil Appleton training center
6. Fox Valley Tech, Kuka Robotics team up on high-tech training center
7. Germantown drug company hires pharma veteran James Davidson as COO
8. Georgia stem cell company likely to stay put
9. Madison stem cell company gets $1M from state
10. Company still behind schedule on Milwaukee wireless project
11. Software company enters health space with RFID solutions on hold
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... ... January 13, 2017 , ... Two Kalamazoo entrepreneurs ... called fulvic acid that farms, greenhouses and hydroponics operations use to increase yields ... the fastest growing segments of customers using this high grade fulvic acid extracted ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... , VTI, Vertebral Technologies, Inc., announces the successful outcome of the first ... September 2016, VTI (Vertebral Technologies, Inc.) has partnered with Mexico-based medical product ...
(Date:1/12/2017)... ... ... Huffman Engineering, Inc. , a leader in control systems integration, today announced ... as a chemical engineer. In his new role, Beck will use his extensive ... manufacturing and water/wastewater industries. , Prior to joining Huffman Engineering, Beck served for nine ...
(Date:1/12/2017)... Conn. , Jan. 12, 2017   ... company and maker of Flublok Influenza Vaccine ... Zika vaccine candidate had good safety results and ... in preclinical studies. The product is expected to ... few months.  In addition, the Institute of Technology ...
Breaking Biology Technology:
(Date:12/8/2016)... -- Market Research Future published a half cooked research report on ... and Service Market is expected to grow over the CAGR of ... ... Mobile Biometric Security and Service Market is increasing ... authentication and security from unwanted cyber threats. The increasing use of ...
(Date:12/7/2016)... BioCatch , the global leader in behavioral ... which grew to over 40 granted and pending patents. ... , , The Company,s ... " System, Device, and Method Estimating Force Applied to a Touch ... forego costly hardware components needed to estimate the force and pressure applied ...
(Date:12/6/2016)... WARSAW, Ind. , Dec. 6, 2016  Zimmer Biomet ... that it has priced an offering of €500.0 million principal ... €500.0 million principal amount of its 2.425% senior unsecured notes ... is expected to occur on December 13, 2016, subject to the ... on an annual basis. ...
Breaking Biology News(10 mins):